LOS ANGELES (AP) — LOS ANGELES (AP) — Renovaro Biosciences Inc. (RENB) on Wednesday reported a loss of $4.5 million in its fiscal second quarter.
The Los Angeles-based company said it had a loss of 7 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RENB at https://www.zacks.com/ap/RENB